EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease

Ayesha Asim, Michał K Jastrzębski, Agnieszka A Kaczor iD

Molecules · 2025-07-15 · 30 (14) · 2975

DOI: 10.3390/molecules30142975 ↗

At a glance

Übersichtsarbeit in Molecules, published online on 2025-07-15. Written by Ayesha Asim and 2 co-authors. Institution: Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical Universi…. Major MEDLINE topics: Alzheimer Disease, Monoamine Oxidase Inhibitors, Cholinesterase Inhibitors, Monoamine Oxidase. Cited 37 times so far (Crossref); 153 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Center.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Alzheimer’s disease (AD) is a multi-factorial neurodegenerative disease with a complex pathomechanism that can be best treated with multi-target medications. Among the possible molecular targets involved in AD, acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B) are well recognized because they control the neurotransmitters responsible for memory processes. This review discusses the current understanding of AD pathology, recent advances in AD treatment, and recent reports in the field of dual AChE/MAO-B inhibitors for treating AD. We provide a classification of dual inhibitors based on their chemical structure and describe active compounds belonging to, i.a., chalcones, coumarins, chromones, imines, and hydrazones. Special emphasis is given to the computer-aided strategies of dual inhibitors design, their structure–activity relationships, and their interactions with the molecular targets at the molecular level.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseMonoamine Oxidase InhibitorsCholinesterase InhibitorsMonoamine OxidaseAcetylcholinesteraseHumansStructure-Activity RelationshipAnimalsMolecular Structure

Author keywords

Acetylcholine Esterase (AChE)Monoamine Oxidase-B (MAO-B)SARdual inhibitorsmolecular modeling

Substances

Monoamine Oxidase InhibitorsCholinesterase InhibitorsMonoamine OxidaseAcetylcholinesterase

Authors and institutions

  • Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., PL-20093 Lublin, Poland.
  • School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, FI-70211 Kuopio, Finland.

ORCID profiles: Agnieszka A Kaczor

Funding

  • National Science Center

Cite

APA

Asim, A., Jastrzębski, M. K., & Kaczor, A. A. (2025). Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease. Molecules, 30(14), 2975. https://doi.org/10.3390/molecules30142975

Vancouver

Asim A, Jastrzębski MK, Kaczor AA. Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease. Molecules. 2025;30(14):2975. doi:10.3390/molecules30142975

BibTeX
@article{Asim2025,
  author = {Asim, Ayesha and Jastrzębski, Michał K and Kaczor, Agnieszka A},
  title = {Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {14},
  pages = {2975},
  doi = {10.3390/molecules30142975}
}
Start for free →